- Home
- NATH vs KMDA Comparison
NATH vs KMDA Comparison
Compare NATH & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATH
- KMDA
- Stock Information
- Founded
- NATH 1916
- KMDA 1990
- Country
- NATH United States
- KMDA Israel
- Employees
- NATH N/A
- KMDA N/A
- Industry
- NATH Restaurants
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- NATH Consumer Discretionary
- KMDA Health Care
- Exchange
- NATH Nasdaq
- KMDA Nasdaq
- Market Cap
- NATH 442.2M
- KMDA 398.5M
- IPO Year
- NATH N/A
- KMDA N/A
- Fundamental
- Price
- NATH $105.16
- KMDA $6.95
- Analyst Decision
- NATH
- KMDA Strong Buy
- Analyst Count
- NATH 0
- KMDA 2
- Target Price
- NATH N/A
- KMDA $13.00
- AVG Volume (30 Days)
- NATH 39.4K
- KMDA 77.7K
- Earning Date
- NATH 11-07-2025
- KMDA 11-12-2025
- Dividend Yield
- NATH 1.90%
- KMDA 2.88%
- EPS Growth
- NATH 9.62
- KMDA 27.97
- EPS
- NATH 5.77
- KMDA 0.32
- Revenue
- NATH $150,413,000.00
- KMDA $169,517,000.00
- Revenue This Year
- NATH N/A
- KMDA $14.49
- Revenue Next Year
- NATH N/A
- KMDA $10.12
- P/E Ratio
- NATH $18.45
- KMDA $21.01
- Revenue Growth
- NATH 6.38
- KMDA 9.67
- 52 Week Low
- NATH $75.15
- KMDA $5.43
- 52 Week High
- NATH $118.50
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- NATH 42.78
- KMDA 52.44
- Support Level
- NATH $106.26
- KMDA $6.72
- Resistance Level
- NATH $109.98
- KMDA $7.11
- Average True Range (ATR)
- NATH 2.50
- KMDA 0.19
- MACD
- NATH -0.44
- KMDA 0.03
- Stochastic Oscillator
- NATH 22.33
- KMDA 60.68
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.